{"id":"W2155012968","doi":"10.1200/jco.2008.16.9847","title":"Bevacizumab Plus Interferon Alfa Compared With Interferon Alfa Monotherapy in Patients With Metastatic Renal Cell Carcinoma: CALGB 90206","year":2008,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":908,"is_retracted":false,"has_abstract":true,"ca_institutions":"CancerCare Manitoba","funders":"National Cancer Institute","keywords":"Medicine; Bevacizumab; Internal medicine; Renal cell carcinoma; Clinical endpoint; Hazard ratio; Gastroenterology; Proteinuria; Oncology; Surgery; Randomized controlled trial; Chemotherapy; Confidence interval; Kidney","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00102837,0.0004339836,0.002862043,0.0003688506,0.00006003113,0.00001194989,0.0003050606,0.000264872,0.0001884634],"category_scores_gemma":[0.0001678828,0.0002577673,0.0004058017,0.0002714891,0.0004476226,0.0001944158,0.00006467792,0.001547481,0.00002555965],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001223235,"about_ca_system_score_gemma":0.002030297,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001792743,"about_ca_topic_score_gemma":0.0002837829,"domain_scores_codex":[0.9945446,0.0007490009,0.002909709,0.0004609263,0.0008225758,0.0005132266],"domain_scores_gemma":[0.9953772,0.0009734219,0.001958423,0.000435883,0.0006257118,0.0006293469],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.2151031,0.009415489,0.7473314,0.0000980348,0.0009463314,0.009744462,0.001417243,0.0004485412,0.0001451931,0.0000052102,0.002773887,0.01257114],"study_design_scores_gemma":[0.08819126,0.1456011,0.7599397,0.0002485718,0.0007093165,0.001114613,0.0002208111,0.000223484,0.0007426508,0.00002194496,0.002698076,0.0002884491],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9955536,0.000566385,0.0004151025,0.001020188,0.0003777134,0.0007097503,0.000009431445,0.0000130085,0.001334855],"genre_scores_gemma":[0.9920803,0.0001240199,0.006304625,0.000798632,0.0002777983,0.0000160232,0.00002901718,0.00006228898,0.0003073386],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1361856,"threshold_uncertainty_score":0.9999875,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0995623420053774,"score_gpt":0.3685206473544246,"score_spread":0.2689583053490472,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}